The management team has in depth experience in drug discovery. Before joining Asclepia, the founders have built their careers in companies such as Janssen Pharmaceutica (part of Johnson & Johnson), UCB, Astra Zeneca, Taminco and Devgen where they developed both scientific and managerial experience.
They have been key contributors in discovery programs and are inventors of multiple New Molecular Entities in the field of Inflammation, Neuroscience and Oncology.
Within the previous companies they worked at, the founders have set up a network of drug discovery CRO ’s. Asclepia has a strong and strategic partnership with Assay Depot (www.assaydepot.com) and is instrumentally involved in the development and implementation of the Assay Depot expansion strategy worldwide.